KUALA LUMPUR: Alpha IVF Group Bhd expects the progressive rollout of new centres to drive stronger growth, reinforcing its position as a leading regional fertility specialist.
“With the progressive rollout of these new centres, the group is expected to achieve a stronger growth trajectory, further strengthening its position as a leading regional fertility treatment specialist,” the fertility care specialist said in a filing with Bursa Malaysia.
It noted that near-term earnings may be impacted by upfront costs from new centre openings and expansion, but expects performance to improve gradually as these centres mature and utilisation rates increase.
Alpha IVF said newly established full-fledged IVF centres in Sabah and Manila have shown an encouraging start and are expected to contribute more meaningfully going forward.
“Beyond these, the group is also developing two additional full-fledged IVF centres, one in Johor, Malaysia, and another overseas centre in Tuguegarao, Philippines, which are expected to be operational by 1H FY27,” it said, adding that it is actively advancing its expansion in Indonesia.
In the third quarter ended Feb 28, Alpha IVF’s net profit rose 4.63% to RM12.4mil, or earnings per share of 0.26 sen, bringing its nine-month profit to RM39.7mil, or 0.82 sen.
Quarterly revenue rose 16.1% to RM47.1mil, lifting its nine-month revenue 15.5% higher at RM146.5mil.
The higher revenue was due to higher sales, especially from local and Chinese patients in the Malaysian centres. The group’s revenue was principally derived from the provision of assisted reproductive services, focusing on in-vitro fertilisation (IVF) treatments
Alpha IVF said demand for assisted reproductive services (ARS) remains resilient and is not directly affected by geopolitical conflicts.
